1. bookVolumen 59 (2009): Edición 2 (June 2009)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance

Publicado en línea: 29 Jun 2009
Volumen & Edición: Volumen 59 (2009) - Edición 2 (June 2009)
Páginas: 171 - 186
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

J. W. Wiechers, The barrier functions of the skin in relation to percutaneous absorption of drugs, Pharm. Weekbl. 11 (1989) 185--198.Search in Google Scholar

D. C. Monkhouse and A. S. Huq, Transdermal drug delivery - problems and promises, Drug Dev. Ind. Pharm. 14 (1988) 183--203.10.3109/03639048809151970Search in Google Scholar

M. B. Brown, G. P. Martin, S. A. Jones and F. K. Akomeah, Dermal and transdermal drug delivery systems: Current and future prospects, Drug Del. 13 (2006) 175--187; DOI: 10.1080/10717540500455975.10.1080/10717540500455975Search in Google Scholar

B. T. Kurihara, W. R. Good, S. Feusullin and C. Signor, Skin compatibility of transdermal drug delivery system, J. Control. Rel. 15 (1991) 271--278; DOI: 10.1016/0168-3659(91)90119-X.10.1016/0168-3659(91)90119-XSearch in Google Scholar

T. Furuishi, S. Oda, H. Saito, T. Fukami, T. Suzuki and K. Tomono, Effect of permeation enhancers on the in vitro percutaneous absorption of pentazocine, Biol. Pharm. Bull. 30 (2007) 1350--1353.Search in Google Scholar

V. Agarwal and B. Mishra, Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine, Drug Dev. Ind. Pharm. 25 (1999) 701--709; DOI: 10.1081/DDC-100102229.10.1081/DDC-100102229Search in Google Scholar

M. Bhattacharyya, S. C. Mandal, B. Sa and B. K. Gupta, Studies on controlled release formulations of pentazocine hydrochloride, Drug Dev. Ind. Pharm. 20 (1994) 1613--1629; DOI: 10.3109/03639049409050202.10.3109/03639049409050202Search in Google Scholar

C. Valenta and B. G. Auner, The use of polymers for dermal and transdermal delivery, Eur. J. Pharm. Biopharm. 58 (2004) 279--289; DOI: 10.1016/j.ejpb.2004.02.017.10.1016/j.ejpb.2004.02.017Search in Google Scholar

United States Pharmacopoeia 25, National Formulary 20, USP Convention, Rockville 2002, pp. 2018.Search in Google Scholar

P. R. P. Verma and S. S. Iyer, Transdermal delivery of propranolol using mixed grades of eudragit: design and in vitro and in vivo evaluation, Drug Dev. Ind. Pharm. 26 (2000) 471--476; DOI: 10.1081/DDC-100101257.10.1081/DDC-100101257Search in Google Scholar

A. R. Chandak and P. R. P. Verma, Development and evaluation of HPMC based matrices for transdermal patches of tramadol, Clin. Res. Reg. Affairs 25 (2008) 13--30; DOI: 10.1080/1060133-0701885066.Search in Google Scholar

M. Man, C. Chang, P. H. Lee, C. T. Broman and G. W. Cleary, New improved paddle method for determining the in vitro drug release profiles of transdermal delivery systems, Control. Rel. 27 (1993) 59--68; DOI: 10.1016/0168-3659(93)90057-C.10.1016/0168-3659(93)90057-CSearch in Google Scholar

B. Berkowitz and E. L. Way, Metabolism and excretion of pentazocine in man, Clin. Pharmacol. Ther. 10 (1969) 681--689.10.1002/cpt19691056815808463Search in Google Scholar

Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-mortem Materials, (Ed. A. C. Moffat), 2nd ed., Pharmaceutical Press, London 1986, pp. 860--861.Search in Google Scholar

S. Wartewig and R. H. H. Neubert, Pharmaceutical applications of Mid-IR and Raman spectroscopy, Adv. Drug Del. Rev. 57 (2005) 1144--1170; DOI: 10.1016/j.addr.2005.01.022.10.1016/j.addr.2005.01.02215885850Search in Google Scholar

T. D. Wilson, Pentazocine, in Analytical Profiles of Drug Substance (Ed. K. Florey), Vol. 13, Pharmaceutical Press, London 1984, pp. 361--416.10.1016/S0099-5428(08)60197-5Search in Google Scholar

R. K. Verma and S. Garg, Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations, J. Pharm. Biomed. Anal. 35 (2004) 449--458; DOI:10.1016/j.jpba.2004.01.012.10.1016/j.jpba.2004.01.01215137971Search in Google Scholar

R. C. Mundargi, S. A. Patil, S. A. Agnihotri and T. M. Aminabhavi, Evaluation and controlled release characteristics of modified xanthan films for transdermal delivery of atenolol, Drug Dev. Ind. Pharm. 33 (2007) 79--90; DOI: 10.1080/03639040600975030.10.1080/0363904060097503017192254Search in Google Scholar

R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25--35; DOI: 10.1016/0378-5173(83) 90064-9.Search in Google Scholar

L. Perioli, V. Ambrogi, D. Rubini, S. Giovagnoli, M. Ricci, P. Blasi and C. Rossi, Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease, J. Control. Rel. 95 (2004) 521--533; DOI: 10.1016/j.jconrel.2003.12.018.10.1016/j.jconrel.2003.12.01815023463Search in Google Scholar

S. Mutalik and N. Udupa, Glibenclamide transdermal patches: Physicochemical, pharmacodynamic, and pharmacokinetic evaluations, J. Pharm. Sci. 93 (2004) 1577--1594; DOI: 10.1002/jps. 20058.Search in Google Scholar

U. D. Rohr, R. Altenburger and T. Kissel, Pharmacokinetics of the transdermal reservoir membrane system delivering β-estradiol: in vitro/in vivo correlation, Pharm. Res. 15 (1998) 877--882.Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo